Before grad school, I spent several years in biomedical research as a laboratory technician, project manager, and clinical trials coordinator. I came to graduate school because I wanted to develop as an independent thinker.

I was working as a hospital pharmacist in Singapore. Our constant struggle, together with other healthcare professionals, with countless unanswered clinical questions in many different medical fields often results in frustration in clinical practice and patient care. My first-hand experience with that struggle inspired and motivated me to contribute to research in the biomedical field.

Broadly, I am interested in understanding how genetic and environmental variation shape phenotypic variation across different timescales.

A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections -- including SARS-CoV-2

After working for a top oil servicing multinational, I decided to use my earnings to pursue a career in medical physics. My plan is to work with other scientists in the field to research and implement accessible and affordable cancer treatment techniques that would be advantageous to low- to middle-income countries (LMICs) like Nigeria. 

I decided to pursue a Master of Biomedical Sciences (MBS) degree to further prepare me for the rigors of a graduate-level curriculum and therefore improve my candidacy for medical school admission.

Congratulations to the 342 students from the Duke University School of Medicine who graduate this month. Despite a historically challenging year, faced with the COVID-19 pandemic and the ongoing impacts of social injustice, students pushed forward with hard work and dedication. We celebrate their many accomplishments and wish them the best in the years ahead.

A new multidisciplinary clinic at Duke plans to provide more seamless treatment for those who have suffered eye strokes.

Duke clinician scientist Anthony Kuo, MD, Associate Professor of Ophthalmology and corneal specialist; and research scientist 

A new $8 million NIH grant seeks to uncover more clues into what genes increase the risk of developing schizophrenia.